Study on the mechanism of preventing alcholic liver disease by selective cyclooxygenase 2 inhibitor.
- Author:
Jun-ying ZHOU
1
;
Dong-fang ZHOU
;
Ying-hui LIU
;
Wei WANG
;
Feng WEI
Author Information
1. Infectious Department, Third Hospital, Hebei Medical University, Shijiazhuang 050051, China. doctorzhoujy@163.com
- Publication Type:Journal Article
- MeSH:
Animals;
Celecoxib;
Cyclooxygenase 1;
genetics;
metabolism;
Cyclooxygenase 2;
genetics;
metabolism;
Cyclooxygenase 2 Inhibitors;
pharmacology;
therapeutic use;
Cytokines;
metabolism;
Disease Models, Animal;
Ethanol;
adverse effects;
Fatty Liver, Alcoholic;
pathology;
prevention & control;
Immunohistochemistry;
Liver;
drug effects;
metabolism;
pathology;
Liver Cirrhosis, Alcoholic;
pathology;
prevention & control;
Liver Diseases, Alcoholic;
pathology;
prevention & control;
Pyrazoles;
pharmacology;
therapeutic use;
RNA, Messenger;
genetics;
metabolism;
Rats;
Reverse Transcriptase Polymerase Chain Reaction;
Sulfonamides;
pharmacology;
therapeutic use
- From:
Chinese Journal of Hepatology
2009;17(7):559-560
- CountryChina
- Language:Chinese